PEPTIPHARMA SRL

Unspecified (Unknown)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£811,645

Jun 13 - Mar 16

Developmental Clinical Studies - A Phase I study of a novel peptide fusion inhibitor for the treatment of chronic HIV infection

MRC award to Imperial College London and Alan Winston

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}